Renalytix plc Form 6-K Current Report Filed 2023-02-08

Por um escritor misterioso

Descrição

Renalytix plc Form 6-K Current Report Filed 2023-02-08
AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Medtronic reports first quarter fiscal 2024 financial results - Aug 22, 2023
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc.
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Stock Market News 2023-05-25
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase - May 25, 2023
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Renalytix plc: Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Federal Register :: Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2024
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Medtronic plc Form 10-K Annual Report Filed 2022-06-23
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Relay Therapeutics, Inc. Form 8-K Current Report Filed 2023-04-18
Renalytix plc Form 6-K Current Report Filed 2023-02-08
Rentokil Initial plc Reports Revenue Results for the Third Quarter of 2023 -October 19, 2023 at 02:00 am EDT
de por adulto (o preço varia de acordo com o tamanho do grupo)